General


Peptide: BMAP-27
Microorganism:Pseudomonas aeruginosa
Administration:
Stage: Preformed biofilm
Notes:Pa9 clinical isolate

Experimental procedure


Method AMP Effect(Biofilm reduction) Concentration Notes
Total countable CFUs 21 - 50% 1.241 uM
Crystal violet assay > 90% 6.203 uM

Reference



M. Di Luca, G. Maccari, G. Maisetta, G. Batoni BaAMPs: the database of biofilm-active antimicrobial peptides Biofouling 2015; 31(2):193-9.

Please do not hesitate to address comments or questions to: mariagrazia.diluca@nano.cnr.it or giuseppe.maccari@iit.it